Global Brain has invested in Chefaa Inc. (Chefaa), an Egypt-based pharmacy benefits platform, through its GB-VII Growth Fund Investment Limited Partnership (GB-VII).

Chefaa is a patient-centric pharmacy benefits startup, which aims to manage chronic illness through a comprehensive approach and improve patients’ compliance through enhancing accessibility to medicine in Egypt. Since Egypt has been suffering from the unsustained access of medical supply particularly for chronic patients, Chefaa provides on-demand service from the nearest pharmacy just through uploading the prescription by patients.

Chefaa also provides the first Arabic speaking pharmaceutical blog as well as 24/7 pharmaceutical consultation as a freemium service to improve the pharmaceutical literacy in Egypt. They are expecting to expand their business in the MENA (Middle East & North Africa) region led by starting the business operation in Saudi Arabia.

Global Brain sees a significant opportunity in the growth of the e-pharmacy industry in the MENA region headed by strong entrepreneurs with vast field experiences.

About Chefaa

Location
Egypt
Representatives
Doaa Aref
Rasha Rady
Founded
2019
URL
https://chefaa.com

About GB-VII

Name
GB-VII Growth Fund Investment Limited Partnership
General Partner
Global Brain Corporation

About Global Brain

Location
Tokyo, Japan
Representative
Yasuhiko Yurimoto
Founded
January 1998
URL
https://globalbrains.com/